Literature DB >> 3003627

Enhancement of transmission at the frog neuromuscular junction by adenosine deaminase: evidence for an inhibitory role of endogenous adenosine on neuromuscular transmission.

A M Sebastião, J A Ribeiro.   

Abstract

Adenosine deaminase reversibly increased the amplitude and the quantum content of the end-plate potentials (EPPs) recorded from superficial muscle fibers of frog sartorius preparations in which twitches have been prevented with high-magnesium solutions. Adenosine deaminase prevented the inhibitory effect of exogenously applied adenosine but not that of 2-chloroadenosine on the amplitude of EPPs. The effect of adenosine deaminase was abolished by erythro-9(2-hydroxy-3-nonyl)adenine (EHNA). The results suggest that endogenous adenosine exerts an inhibitory 'tone' over neuromuscular transmission.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3003627     DOI: 10.1016/0304-3940(85)90366-0

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  On the role, inactivation and origin of endogenous adenosine at the frog neuromuscular junction.

Authors:  J A Ribeiro; A M Sebastião
Journal:  J Physiol       Date:  1987-03       Impact factor: 5.182

2.  Modulation of stimulation-evoked release of newly formed acetylcholine from mouse hemidiaphragm preparation.

Authors:  G T Somogyi; E S Vizi; I A Chaudhry; H Nagashima; D Duncalf; F F Foldes; P L Goldiner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

3.  Endogenous adenosine modulates stimulation-induced depression at the frog neuromuscular junction.

Authors:  S D Meriney; A D Grinnell
Journal:  J Physiol       Date:  1991-11       Impact factor: 5.182

4.  A2B adenosine receptors mediate relaxation of the pig intravesical ureter: adenosine modulation of non adrenergic non cholinergic excitatory neurotransmission.

Authors:  M Hernández; M V Barahona; S Bustamante; A García-Sacristán; L M Orensanz
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

5.  Inhibition of spontaneous acetylcholine secretion by 2-chloroadenosine as revealed by a protein kinase inhibitor at the mouse neuromuscular junction.

Authors:  Jody K Hirsh; Eugene M Silinsky
Journal:  Br J Pharmacol       Date:  2002-04       Impact factor: 8.739

6.  The influence of 2-chloroadenosine on potassium-evoked and neurally-evoked acetylcholine secretion from normal or from latent active zones in the frog.

Authors:  E M Silinsky
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

7.  The effect of reduced temperature on the inhibitory action of adenosine and magnesium ion at frog motor nerve terminals.

Authors:  E M Silinsky; J K Hirsh
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

8.  Pharmacological characterization of adenosine A1 and A2 receptors in the bladder: evidence for a modulatory adenosine tone regulating non-adrenergic non-cholinergic neurotransmission.

Authors:  C G Acevedo; E Contreras; J Escalona; J Lewin; J P Huidobro-Toro
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

9.  Probabilistic secretion of quanta from nerve terminals in avian ciliary ganglia modulated by adenosine.

Authors:  M R Bennett; S Ho
Journal:  J Physiol       Date:  1991       Impact factor: 5.182

Review 10.  Amyotrophic Lateral Sclerosis (ALS) and Adenosine Receptors.

Authors:  Ana M Sebastião; Nádia Rei; Joaquim A Ribeiro
Journal:  Front Pharmacol       Date:  2018-04-16       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.